| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.22B | 141.60B | 148.97B | 137.66B | 138.38B | 140.44B |
| Gross Profit | 34.64B | 35.41B | 36.93B | 33.54B | 32.79B | 32.30B |
| EBITDA | 9.58B | 9.89B | 14.90B | 8.26B | 7.11B | 6.67B |
| Net Income | 4.13B | 4.31B | 7.34B | 3.26B | 2.10B | 1.64B |
Balance Sheet | ||||||
| Total Assets | 93.61B | 98.01B | 95.39B | 87.93B | 98.07B | 97.98B |
| Cash, Cash Equivalents and Short-Term Investments | 12.16B | 16.74B | 21.34B | 18.12B | 22.30B | 17.08B |
| Total Debt | 12.79B | 13.18B | 5.58B | 7.67B | 10.22B | 15.79B |
| Total Liabilities | 36.48B | 41.36B | 37.90B | 36.91B | 49.75B | 50.95B |
| Stockholders Equity | 57.12B | 56.64B | 57.48B | 49.20B | 46.64B | 45.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.22B | 3.85B | -727.00M | 9.19B | 4.96B |
| Operating Cash Flow | 0.00 | 4.92B | 11.19B | 3.10B | 11.46B | 11.37B |
| Investing Cash Flow | 0.00 | -12.57B | -4.55B | -3.82B | -2.75B | -6.65B |
| Financing Cash Flow | 0.00 | 3.06B | -3.42B | -3.47B | -3.48B | 4.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥778.71B | 19.01 | 19.13% | 2.64% | 7.58% | 15.12% | |
66 Neutral | ¥129.43B | 8.08 | ― | 2.82% | 11.66% | -7.47% | |
63 Neutral | ¥60.70B | 10.40 | ― | 4.49% | 8.56% | -13.47% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥27.30B | 9.94 | ― | 4.79% | -6.89% | -50.31% | |
53 Neutral | ¥247.82B | 16.36 | ― | 1.24% | 21.79% | 9.89% | |
48 Neutral | ¥4.51B | -10.59 | ― | 1.08% | -2.36% | -1738.42% |